Systemic Therapy for Melanoma: ASCO Guideline von Seth, Rahul, Messersmith, Hans, Kaur, Varinder, Kirkwood, John M, Kudchadkar, Ragini, McQuade, Jennifer Leigh, Provenzano, Anthony, Swami, Umang, Weber, Jeffrey, Alluri, Krishna C, Agarwala, Sanjiv, Ascierto, Paolo A, Atkins, Michael B, Davis, Nancy, Ernstoff, Marc S, Faries, Mark B, Gold, Jason S, Guild, Samantha, Gyorki, David E, Khushalani, Nikhil I, Meyers, Michael O, Robert, Caroline, Santinami, Mario, Sehdev, Amikar, Sondak, Vernon K, Spurrier, Gilliosa, Tsai, Katy K, van Akkooi, Alexander, Funchain, Pauline

Volltext

Landmark Series on Disparities in Surgical Oncology: Melanoma von Asare, Elliot A., Swami, Umang, Stewart, John H.

Volltext

Eribulin in Cancer Treatment von Swami, Umang, Shah, Umang, Goel, Sanjay

Volltext

Harnessing DNA Replication Stress for Novel Cancer Therapy von Zhu, Huanbo, Swami, Umang, Preet, Ranjan, Zhang, Jun

Volltext

Recent Advances in the Management of Metastatic Prostate Cancer von Sayegh, Nicolas, Swami, Umang, Agarwal, Neeraj

Volltext

Radium‐223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration‐Refractory Prostate Cancer: Final Safety and Efficacy Results von Maughan, Benjamin L., Kessel, Adam, McFarland, Taylor Ryan, Sayegh, Nicolas, Nussenzveig, Roberto, Hahn, Andrew W., Hoffman, John M., Morton, Kathyrn, Sirohi, Deepika, Kohli, Manish, Swami, Umang, Boucher, Kenneth, Haaland, Benjamin, Agarwal, Neeraj

Volltext

PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape von Al-Akhras, Ashaar, Hage Chehade, Chadi, Narang, Arshit, Swami, Umang

Volltext

Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancer von Swami, Umang, Agarwal, Neeraj

Volltext

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial von Coletta, Adriana M, Simon, Lea Haverbeck, Maslana, Kelsey, Taylor, Sarah, Larson, Kish, Hansen, Pamela A, Thomas, Vinay Mathew, Ulrich, Cornelia M, Kohli, Manish, Chipman, Jonathan, Swami, Umang, Gupta, Sumati, Maughan, Benjamin L, Agarwal, Neeraj

Volltext

Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience von Swami, Umang, Grivas, Petros, Pal, Sumanta K., Agarwal, Neeraj

Volltext

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome von Marsiglio, John, McPherson, Jordan P, Kovacsovics-Bankowski, Magdalena, Jeter, Joanne, Vaklavas, Christos, Swami, Umang, Grossmann, Douglas, Erickson-Wayman, Alyssa, Soares, Heloisa P, Kerrigan, Katie, Gibson, Berit, Doherty, Jennifer Anne, Hyngstrom, John, Hardikar, Sheetal, Hu-Lieskovan, Siwen

Volltext

Current management of metastatic castration-sensitive prostate cancer von Kessel, Adam, Kohli, Manish, Swami, Umang

Volltext

Intraperitoneal seeding of a testicular mixed germ cell tumor following spontaneous intraperitoneal mass rupture with associated anti-NMDA paraneoplastic encephalitis von Marshall, Morgan B., Dindinger-Hill, Kassandra, Swami, Umang, Lyden, Stephanie, Sanchez, Alejandro

Volltext

Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix von Campbell, Patrick, Gebrael, Georges, Narang, Arshit, Chehade, Chadi Hage, Thomas, Vinay Mathew, Galarza Fortuna, Gliceida, Sayegh, Nicolas, Tripathi, Nishita, Tandar, Clara, Dal, Emre, Li, Haoran, Swami, Umang, Agarwal, Neeraj, Maughan, Benjamin L

Volltext

Drug development in metastatic prostate cancer: lessons from ACIS von Swami, Umang, Agarwal, Neeraj

Volltext

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma von Pokorny, Rebecca, McPherson, Jordan P, Haaland, Benjamin, Grossmann, Kenneth F, Luckett, Carolyn, Voorhies, Benjamin Newell, Sageser, Daniel S, Wallentine, Jocelyn, Tolman, Zachary, Hu-Lieskovan, Siwen, Swami, Umang

Volltext

Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case report von McFarland, Taylor Ryan, Tandar, Clara Elizabeth, Agarwal, Neeraj, Swami, Umang

Volltext

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden von Florou, Vaia, Floudas, Charalampos S, Maoz, Asaf, Naqash, Abdul Rafeh, Norton, Carter, Tan, Aik Choon, Sokol, Ethan S, Frampton, Garrett, Soares, Heloisa P, Puri, Sonam, Swami, Umang, Wilky, Breelyn, Hosein, Peter, Trent, Jonathan, Lopes, Gilberto de Lima, Park, Wungki, Garrido-Laguna, Ignacio

Volltext

Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma von Dal, Emre, Srivastava, Ayana, Chigarira, Beverly, Hage Chehade, Chadi, Matthew Thomas, Vinay, Galarza Fortuna, Gliceida M, Garg, Diya, Ji, Richard, Gebrael, Georges, Agarwal, Neeraj, Swami, Umang, Li, Haoran

Volltext

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA von Swami, Umang, Zimmerman, Raquel Mae, Nussenzveig, Roberto H, Hernandez, Edgar Javier, Jo, Yeonjung, Sayegh, Nicolas, Wesolowski, Sergiusz, Kiedrowski, Lesli A, Barata, Pedro C, Lemmon, Gordon Howard, Bilen, Mehmet A, Heath, Elisabeth I, Nandagopal, Lakshminarayan, Babiker, Hani M, Pal, Sumanta K, Lilly, Michael, Maughan, Benjamin L, Haaland, Benjamin, Yandell, Mark, Sartor, Oliver, Agarwal, Neeraj

Volltext